ESR1 and triple-negative breast carcinoma: MDA-MB-231 is a type of triple-negative breast cancer cell line with negative expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her2), and usually as endogenous resistant breast cancer cells.